Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.39% | 244.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.39% | 244.78% | |||
| Cost of Revenue | -1.59% | 100.56% | |||
| Gross Profit | 27.72% | 621.57% | |||
| SG&A Expenses | 4.50% | 5.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.44% | 4.79% | |||
| Operating Income | 5.01% | 16.44% | |||
| Income Before Tax | 4.58% | 17.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.58% | 17.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.58% | 17.03% | |||
| EBIT | 5.01% | 16.44% | |||
| EBITDA | 5.17% | 17.21% | |||
| EPS Basic | 10.34% | 19.44% | |||
| Normalized Basic EPS | 11.11% | 18.18% | |||
| EPS Diluted | 10.34% | 19.44% | |||
| Normalized Diluted EPS | 11.11% | 18.18% | |||
| Average Basic Shares Outstanding | 9.28% | 1.18% | |||
| Average Diluted Shares Outstanding | 9.28% | 1.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
